Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study

Standard

Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study. / Eyer, Florian; Pfab, Rudolf; Felgenhauer, Norbert; Strubel, Tim; Saugel, Bernd; Zilker, Thomas.

in: CLIN TOXICOL, Jahrgang 49, Nr. 9, 01.11.2011, S. 846-53.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{971d9bbad7f349fdbdcc882bf0cbad1f,
title = "Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study",
abstract = "CONTEXT: Detailed data on severe overdoses with quetiapine are relatively sparsely reported in the literature.OBJECTIVE: To describe a cohort of 20 acute quetiapine overdoses and provide additional data on the pharmacokinetics and clinical features of intoxication with this drug.MATERIAL AND METHODS: A retrospective study was conducted on patients with quetiapine poisoning admitted to our institution. We included moderate to severe overdoses between 2005-2011 who required admission to ICU.RESULTS: Predominantly female patients (n = 17) ingested a median dose of 9.8 g quetiapine. Poison Severity Score was moderate in 9 patients, severe in 10 patients and in one case fatal. Quetiapine was analytically confirmed in all cases. Clinical manifestations included drowsiness or coma (all patients), tachycardia (12 patients) and hypotension (10 patients). Seizures and arrhythmia occurred in 4 patients, each. Intubation and mechanical ventilation was required in 14 patients due to seizures, respiratory depression or loss of airway protection and 15 patients developed pneumonia. Hypokalaemia and hyperglycaemia were present at admission in 10 and 5 patients, respectively. Despite frequent prolongation of the QT(c) in 13 patients, QT interval was normal in most cases and QRS-interval was prolonged in only one patient. Presumably anticholinergic delirium was recognised in 8 patients and 6 patients received physostigmine with good clinical response. In 13 cases quetiapine was analysed quantitatively in serum with a relevantly prolonged half-life (16 ± 12 h) and a median peak serum concentration of 3074 ng/mL. In 4 of these 13 patients we observed an increase of quetiapine serum concentration in the further course.CONCLUSION: In this study, quetiapine overdoses were associated with significant toxicity and a fairly high number of complications. A careful and often prolonged clinical observation in the more severe cases of overdose seems mandatory.",
keywords = "Adult, Antipsychotic Agents, Arrhythmias, Cardiac, Cohort Studies, Coma, Dibenzothiazepines, Drug Overdose, Female, Half-Life, Humans, Hypotension, Intensive Care Units, Male, Middle Aged, Pneumonia, Retrospective Studies, Tachycardia",
author = "Florian Eyer and Rudolf Pfab and Norbert Felgenhauer and Tim Strubel and Bernd Saugel and Thomas Zilker",
year = "2011",
month = nov,
day = "1",
doi = "10.3109/15563650.2011.624100",
language = "English",
volume = "49",
pages = "846--53",
journal = "CLIN TOXICOL",
issn = "1556-3650",
publisher = "informa healthcare",
number = "9",

}

RIS

TY - JOUR

T1 - Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study

AU - Eyer, Florian

AU - Pfab, Rudolf

AU - Felgenhauer, Norbert

AU - Strubel, Tim

AU - Saugel, Bernd

AU - Zilker, Thomas

PY - 2011/11/1

Y1 - 2011/11/1

N2 - CONTEXT: Detailed data on severe overdoses with quetiapine are relatively sparsely reported in the literature.OBJECTIVE: To describe a cohort of 20 acute quetiapine overdoses and provide additional data on the pharmacokinetics and clinical features of intoxication with this drug.MATERIAL AND METHODS: A retrospective study was conducted on patients with quetiapine poisoning admitted to our institution. We included moderate to severe overdoses between 2005-2011 who required admission to ICU.RESULTS: Predominantly female patients (n = 17) ingested a median dose of 9.8 g quetiapine. Poison Severity Score was moderate in 9 patients, severe in 10 patients and in one case fatal. Quetiapine was analytically confirmed in all cases. Clinical manifestations included drowsiness or coma (all patients), tachycardia (12 patients) and hypotension (10 patients). Seizures and arrhythmia occurred in 4 patients, each. Intubation and mechanical ventilation was required in 14 patients due to seizures, respiratory depression or loss of airway protection and 15 patients developed pneumonia. Hypokalaemia and hyperglycaemia were present at admission in 10 and 5 patients, respectively. Despite frequent prolongation of the QT(c) in 13 patients, QT interval was normal in most cases and QRS-interval was prolonged in only one patient. Presumably anticholinergic delirium was recognised in 8 patients and 6 patients received physostigmine with good clinical response. In 13 cases quetiapine was analysed quantitatively in serum with a relevantly prolonged half-life (16 ± 12 h) and a median peak serum concentration of 3074 ng/mL. In 4 of these 13 patients we observed an increase of quetiapine serum concentration in the further course.CONCLUSION: In this study, quetiapine overdoses were associated with significant toxicity and a fairly high number of complications. A careful and often prolonged clinical observation in the more severe cases of overdose seems mandatory.

AB - CONTEXT: Detailed data on severe overdoses with quetiapine are relatively sparsely reported in the literature.OBJECTIVE: To describe a cohort of 20 acute quetiapine overdoses and provide additional data on the pharmacokinetics and clinical features of intoxication with this drug.MATERIAL AND METHODS: A retrospective study was conducted on patients with quetiapine poisoning admitted to our institution. We included moderate to severe overdoses between 2005-2011 who required admission to ICU.RESULTS: Predominantly female patients (n = 17) ingested a median dose of 9.8 g quetiapine. Poison Severity Score was moderate in 9 patients, severe in 10 patients and in one case fatal. Quetiapine was analytically confirmed in all cases. Clinical manifestations included drowsiness or coma (all patients), tachycardia (12 patients) and hypotension (10 patients). Seizures and arrhythmia occurred in 4 patients, each. Intubation and mechanical ventilation was required in 14 patients due to seizures, respiratory depression or loss of airway protection and 15 patients developed pneumonia. Hypokalaemia and hyperglycaemia were present at admission in 10 and 5 patients, respectively. Despite frequent prolongation of the QT(c) in 13 patients, QT interval was normal in most cases and QRS-interval was prolonged in only one patient. Presumably anticholinergic delirium was recognised in 8 patients and 6 patients received physostigmine with good clinical response. In 13 cases quetiapine was analysed quantitatively in serum with a relevantly prolonged half-life (16 ± 12 h) and a median peak serum concentration of 3074 ng/mL. In 4 of these 13 patients we observed an increase of quetiapine serum concentration in the further course.CONCLUSION: In this study, quetiapine overdoses were associated with significant toxicity and a fairly high number of complications. A careful and often prolonged clinical observation in the more severe cases of overdose seems mandatory.

KW - Adult

KW - Antipsychotic Agents

KW - Arrhythmias, Cardiac

KW - Cohort Studies

KW - Coma

KW - Dibenzothiazepines

KW - Drug Overdose

KW - Female

KW - Half-Life

KW - Humans

KW - Hypotension

KW - Intensive Care Units

KW - Male

KW - Middle Aged

KW - Pneumonia

KW - Retrospective Studies

KW - Tachycardia

U2 - 10.3109/15563650.2011.624100

DO - 10.3109/15563650.2011.624100

M3 - SCORING: Journal article

C2 - 22077248

VL - 49

SP - 846

EP - 853

JO - CLIN TOXICOL

JF - CLIN TOXICOL

SN - 1556-3650

IS - 9

ER -